Invention Grant
US07396524B2 Methods for screening compounds for proarrhythmic risk and antiarrhythmic efficacy
失效
筛选化合物用于心律失常风险和抗心律失常药效的方法
- Patent Title: Methods for screening compounds for proarrhythmic risk and antiarrhythmic efficacy
- Patent Title (中): 筛选化合物用于心律失常风险和抗心律失常药效的方法
-
Application No.: US11194983Application Date: 2005-08-02
-
Publication No.: US07396524B2Publication Date: 2008-07-08
- Inventor: Gan-Xin Yan
- Applicant: Gan-Xin Yan
- Applicant Address: US PA Wynnewood
- Assignee: Main Line Health Heart Center
- Current Assignee: Main Line Health Heart Center
- Current Assignee Address: US PA Wynnewood
- Agency: Ratner Prestia
- Main IPC: A61K49/00
- IPC: A61K49/00

Abstract:
Methods for screening compounds for their potential to induce or inhibit a cardiac arrhythmia are disclosed. The methods comprise determining the ratio of the time constant (τ) of ICa,L recovery in tissue expressing the L-type calcium channel or any subunit or combination thereof of the L-type calcium channel treated with a test compound to the ventricular repolarization time of cardiac tissue treated with a test compound. The methods further comprise determining an arrhythmic risk score for a specified dose of a test compound.
Public/Granted literature
- US20070031817A1 Methods for screening compounds for proarrhythmic risk and antiarrhythmic efficacy Public/Granted day:2007-02-08
Information query